Clinical Pharmacokinetics

, Volume 2, Issue 2, pp 73–92 | Cite as

Serum Level Monitoring and Clinical Pharmacokinetics of Lithium

  • Amdi Amdisen


Short-term antimanic therapy with lithium and relapse-repressive, so-called ‘prophylactic’ long-term therapy with lithium, may present clinical problems which demand an understanding of two cardinal properties of this form of therapy — the need to individualise the dose and the recognition that successful therapy involves the use of near-toxic dosage. Therefore, treatment must be constantly supervised, not only by the physician but also primarily by the patient himself, especially to avoid the ever-present risk of intoxication.

Results of 25 years’ clinical experience and more recent knowledge of the clinical pharmacokinetics of the lithium ion have shown that a serum level standardised with regard to dosage schedule, a fixed interval between last intake and blood sampling, blood sampling at the same hour, and choice of tablet brand, must all be considered essential to adjust dosage and to correctly monitor treatment.

Optimum use of the lithium ion as a psychotherapeutic drug and of the standardised 12 hour lithium serum concentration, presupposes that the pharmacokinetics of the lithium ion are well understood by the clinician.


Lithium Clinical Pharmacokinetic Lithium Chloride Lithium Concentration Lithium Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albrecht, J. and Muller-Oerlinghausen, B.: Zur klinischen Bedeutung der intraerythrozytaren Lithiumkonzentration: Ergebnisse einer Katamnestischen Studie. Arzneimittel-Forschung 26: 1–3 (1976).Google Scholar
  2. Amdisen, A.: Serum lithium determinations for clinical use. Scandinavian Journal of Clinical and Laboratory Investigation 20: 104–108 (1967).CrossRefGoogle Scholar
  3. Amdisen, A.: Monitoring of lithium treatment through determination of lithium concentration. Danish Medical Bulletin 22: 277–291 (1975a).PubMedGoogle Scholar
  4. Amdisen, A.: The estimation of lithium in urine; in Johnson (Ed.) Lithium Research and Therapy pp. 181–195 (Academic Press, New York 1975b).Google Scholar
  5. Amdisen, A.: Sustained-release preparations of lithium; in Johnson (Ed.) Lithium Research and Therapy, pp. 197–210 (Academic Press, New York 1975c).Google Scholar
  6. Amdisen, A. and Baastrup, P.C.: Unpublished data (1977).Google Scholar
  7. Amdisen, A.; Baastrup, P.C. and Schou, M.: Lithiumbehandling. Manedsskrift for Praktisk Laegegerning 47: 337–352 (1969).Google Scholar
  8. Amdisen, A.; Gottfries, C.G.; Jacobsson, L. and Winblad, B.: Grave lithium intoxication with fatal outcome. Acta psychiatrica scandinavica Suppl. 255: 25–33 (1974).CrossRefGoogle Scholar
  9. Amdisen, A. and Sjogren, J.: Lithium absorption from sustained-release tablets (Duretter®). Acta Pharmaceutica Suecica 5: 465–472 (1968).PubMedGoogle Scholar
  10. Ashburner, J.V.: A case of chronic mania treated with lithium citrate and terminating fatally. Medical Journal of Australia 37: 386 (1950).Google Scholar
  11. Baastrup, P.C. and Schou, M.: Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychoses. Archives of General Psychiatry 16: 162–172 (1967).PubMedCrossRefGoogle Scholar
  12. Baastrup, P.C.: Lithium in prophylaxis. Current Psychiatric Therapy 9: 125–131 (1969).Google Scholar
  13. Baastrup, P.C.; Poulsen, J.C.; Schou, M.; Thomsen, K. and Amdisen, A.: Prophylactic lithium: Double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 2: 326–330 (1970).PubMedCrossRefGoogle Scholar
  14. Baastrup, P.C.: Practical problems concerning lithium maintenance therapy; in Vinar, Votava and Bradley (Eds.) Advances in Neuro-Psychopharmacology, pp.39–42 (North-Holland, Amsterdam 1971).Google Scholar
  15. Baer, L.; Glassman, H. and Kassir, S.: Negative sodium balance in lithium carbonate toxicity. Archives of General Psychiatry 29: 823–827 (1973).PubMedCrossRefGoogle Scholar
  16. Biniek, E.: Biochemische und Klinische Befunde bei verschiedenen Lithiumpraparaten. Zentralblatt fur die gesamte Neurologie und Psychiatrie. Referatenteil des Archivs fur Psychiatrie und Nervenkrankheiten 204: 124 (1972).Google Scholar
  17. Cade, J.F.J.: Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia 36: 349–352 (1949).Google Scholar
  18. Caldwell, H.C.; Westlake, W.J.; Connor, S.M. and Flannagan, T.: A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man. Journal of Clinical Pharmacology 11: 349–356 (1971).Google Scholar
  19. Cooper, T.B.; Bergner, P.E.E. and Simpson, G.M.: The 24-hour serum level as a prognosticator of dosage requirements. American Journal of Psychiatry 130: 601–603 (1973).PubMedGoogle Scholar
  20. Cooper, T.B. and Simpson, G.M.: The 24-hour lithium level as a prognosticator of dosage requirements: A two-year follow-up study. American Journal of Psychiatry 133: 440–443 (1976).PubMedGoogle Scholar
  21. Coppen, A.; Bailey, J.E. and White, S.C.: Slow-release lithium carbonate. Journal of Clin. Pharmacol. 9: 160–163 (1969).Google Scholar
  22. Coppen, A.; Noguera, R.; Bailey, J.; Burns, B.H.; Swani, M.S.; Hare, E.H.; Gardner, R. and Maggs, R.: Prophylactic lithium in affective disorders. Controlled trial. Lancet 2: 275–279 (1971).Google Scholar
  23. Cundall, R.L.; Brooks, P.W., and Murray, L.G.: A controlled evaluation of lithium prophylaxis in affective disorders. Psychological Medicine 2: 308–311 (1972).PubMedCrossRefGoogle Scholar
  24. Demisch, L. and Bochnik, H.J.: Zur Verbesserung der Lithiumprophylaxe endogen phasishcer Psychosen: Aspekte der parallelen Lithiumbestimmung in Serum und in Erythrozyten. Arzneimittel-Forschung 26: 5–8 (1976).Google Scholar
  25. Dick, P.: Les effets secondaires des traitements au lithium (Premiers resultats d’une enquete). Therapeutische Umschau/Revue therapeutique 32: 532–535 (1975).Google Scholar
  26. Evan, A.P. and Ollerich, D.A.: The effect of lithium carbonate on the structure of the rat kidney. American Journal of Anatomy 134: 87–106 (1972).CrossRefGoogle Scholar
  27. Greil, W.; Eisenried, F. and Duhm, J.: Uber die Verteilung von Lithium zwischen Erythrozyten und Plasma: In vitro-Untersuchung zum Transport von Lithium an menchlichen Erythrozyten. Arzneimittel-Forschung 26: 3–5 (1976).Google Scholar
  28. Hansen, H.E. and Amdisen, A.: Lithium intoxication. Submitted for publication (1976).Google Scholar
  29. Hestbech, J.; Hansen, H.E.; Amdisen, A. and Olsen, S.: Renal lesions following long-term treatment with lithium salts. Submitted for publication (1976).Google Scholar
  30. Hewick, D.S. and Murray, N.: Red-blood-cell levels and lithium toxicity. Lancet 2: 473 (1976).PubMedCrossRefGoogle Scholar
  31. Hullin, R.P.; McDonald, R. and Allsopp, M.N.E.: Prophylactic lithium in recurrent effective disorder. Lancet 1: 1044–1046 (1972).PubMedCrossRefGoogle Scholar
  32. Jenner, F.A. and Lee, C.R.: Intracellular lithium and clinical response. Lancet 2: 641–642 (1976).PubMedCrossRefGoogle Scholar
  33. Lee, C.R.; Hill, S.E.; Dimitrakoudi, M.; Jenner, F.A. and Pollitt, R.J.: The relationship of plasma to erythrocyte lithium levels in patients taking lithium carbonate. British Journal of Psychiatry 127: 596–598 (1975).PubMedCrossRefGoogle Scholar
  34. Lehmann, K. and Merten, K.: Die Elimination von Lithium in Abhangigkeit vom Lebensalter bei Gesunden und Nierenin-suffizienten. International Journal of Clinical Pharmacology 10:292–298 (1974).Google Scholar
  35. Lyttkens. L., Soderberg. U. and Wetterberg, L.: Relation between erythrocyte and plasma lithium concentrations as an index in psychiatric disease. Uppsala Journal of Medical Science 81: 123–128 (1976).CrossRefGoogle Scholar
  36. Matussek, N. and v.Hessling, P.: Vergleich von Lithium-Neben-Wirkungen zwichen einem Kurzzeit-(Quilonum®) und einem Depot-praparat (Lithium Durules®). Nervenarzt 42: 376–378 (1971).PubMedGoogle Scholar
  37. Mendels, J. and Frazer, A.: Intracellular lithium concentration and clinical response: Towards a membering theory of depression. Journal of Psychiatric Research 10: 9–18 (1973).PubMedCrossRefGoogle Scholar
  38. Muniz, C.; Forman, A.M.; Wilder, B.J. and Ramsay, R.E.: Lithium toxicity with low serum levels: Report of a case. Clinical Electroencephalography 7: 31–34 (1976).Google Scholar
  39. Noack, C.H. and Trautner, E.M.: The lithium treatment of maniacal-psychoses. Medical Journal of Australia 38, 219–222 (1951).Google Scholar
  40. Olesen, O.V. and Thomsen, K.: A preventive effect of potassium against fatal lithium intoxication in rats. Neruopsychobiology 2: 112–117 (1976).CrossRefGoogle Scholar
  41. Petersen, V.; Hvidt, S.; Thomsen, K. and Schou, M.: Effect of prolonged thiazide treatment on renal lithium clearance. British Medical Journal 3: 143–145 (1974).PubMedCrossRefGoogle Scholar
  42. Prien, R.F. and Caffey, E.M.: Relationship between dosage and response to lithium prophylaxis in recurrent depression. American Journal of Psychiatry 133: 567–570 (1976).PubMedGoogle Scholar
  43. Prien, R.F.; Caffey, E.M. and Klett, C.J.: Relationship between serum lithium levels and clinical response in acute mania treated with lithium. British Journal of Psychiatry 120: 409–414 (1972).PubMedCrossRefGoogle Scholar
  44. Rafaelsen, O.J.: Manic-depressive psychoses or manic-melancholic mode. Danish Medical Bulletin 21: 81–88 (1974).PubMedGoogle Scholar
  45. Roberts, E.L.: A case of chronic mania treated with lithium citrate and terminating fatally. Medical Journal of Australia 37: 261 (1950).Google Scholar
  46. Schou, M.: Lithium in psychiatric therapy and prophylaxis. Journal of Psychiatric Research 6: 67–95 (1968).PubMedCrossRefGoogle Scholar
  47. Schou, M.; Amdisen, A. and Baastrup, P.C.: The practical management of lithium treatment. British Journal of Hospital Medicine 6: 53–60 (1971).Google Scholar
  48. Schou, M.; Amdisen, A. and Steenstrup, O.R.: Lithium and pregnancy. II. Hazards to women given lithium during pregnancy and delivery. British Medical Journal 2: 137–138 (1973).PubMedCrossRefGoogle Scholar
  49. Schou, M.; Juel-Nielsen, N.; Stromgren, E. and Voldby, H.: The treatment of manic psychoses by the administration of lithium salts. Journal of Neurology, Neurosurgery and Psychiatry 17: 250–260 (1954).CrossRefGoogle Scholar
  50. Schou, M.; Juel-Nielsen, N.; Stromgren, E. and Voldby, H.: Behandling af maniske psykoser med lithium Ugeskrift for Laeger 117: 93–101 (1955).Google Scholar
  51. Schou, M. and Shaw, D.M.: Lithium in recurrent manicdepressive disorder. Practitioner 210: 105–111 (1973).PubMedGoogle Scholar
  52. Seifert, R.; Bremkamp, H. and Junge, C.: Vereinfachte Lithiumeinstellung durch Belastungstest. Psychopharmacologia (Berl.) 43: 285–286 (1975).CrossRefGoogle Scholar
  53. Stallone, F.; Shelley, E.; Mendlewicz, J. and Fieve, K.R.: The use of lithium in affective disorders III: A double-blind prophylaxis in bipolar illness. American Journal of Psychiatry 130: 1006–1010 (1973).PubMedGoogle Scholar
  54. Stokes, P.E.; Stoll, P.M.; Shaemoian, C.A. and Patton, M.J.: Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1: 1319–1325 (1971).PubMedCrossRefGoogle Scholar
  55. Thomsen, K. and Schou, M.: Renal lithium excretion in man. American Journal of Physiology 215: 823–827 (1968).PubMedGoogle Scholar
  56. Thomsen, K.: The effect of sodium chloride on kidney function in rats with lithium intoxication. Acta Pharmacologica et Toxicologica 33: 92–102 (1973).PubMedCrossRefGoogle Scholar
  57. Trautner, E.M.; Morris, R.; Noack, C.H. and Gershon, S.: The excretion and retention of ingested lithium and its effect on the ionic balance of man. Medical Journal of Australia 42: 280–291 (1955).PubMedGoogle Scholar
  58. Tyrer, S.; Hullin, R.P.; Birch, N.J. and Goodwin, J.C.: Absorption of lithium following administration of slow-release and conventional preparations. Psychological Medicine 6: 51–58 (1976).PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press 1977

Authors and Affiliations

  • Amdi Amdisen
    • 1
  1. 1.Psychopharmacological Research Unit, Psychiatric University ClinicPsychiatric HospitalAarhusDenmark

Personalised recommendations